Arix Bioscience (ARIX)

 

ARIX Share PerformanceMore

52 week high220.00 28/02/18
52 week low167.50 16/08/17
52 week change 6.85 (3.37%)
4 week volume1,416,219 29/04/18
price209.35
price date1527257919
close209.00

Media for (ARIX)

Presenter: Jonathan Peacock
05/03/2018

Latest NewsMore

Iterum Therapeutics plc Prices Initial Public Offering

Iterum Therapeutics plc Prices Initial Public Offering LONDON, 25 May 2018 Arix Bioscience plc (LSE:ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation, today notes that its Group Business Iterum Therapeutics plc (NASDAQ: ITRM), a clinical-stage pharmaceutical company developing anti-infectives aimed at combatting th...

Result of AGM

RNS Number: 4558O Arix Bioscience Plc 17 May 2018 Arix Bioscience Plc Results of Annual General Meeting LONDON, 17 May, 2018: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or the "Company"), a global healthcare and life science company supporting medical innovation, announces that its Annual General Meeting (the "Meeting") was held on Thursday 1...

Update on Iterum proposed NASDAQ IPO

RNS Number: 3518O Arix Bioscience Plc 17 May 2018 Arix Bioscience plc Update on Iterum proposed NASDAQ IPO 17 May 2018 Arix Bioscience plc (LSE:ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation, notes that its Group Business Iterum Therapeutics ("Iterum") a clinical-stage pharmaceutical company developing anti-in...

Autolus Files for Proposed US IPO

RNS Number: 2676N Arix Bioscience Plc 08 May 2018 Arix Bioscience plc Autolus files for proposed initial public offering in the United States LONDON, 8 May 2018 Arix Bioscience plc (LSE:ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation, today notes that, its largest Group Business holding, Autolus Therapeutics Limited ...

Arix notes Iterum?s proposed US IPO

RNS Number: 8795M Arix Bioscience Plc 02 May 2018 Arix Bioscience plc Iterum announces confidential submission of draft registration statement for proposed initial public offering in the United States 2 May 2018 Arix Bioscience plc (LSE:ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation, today notes that its Group Busin...

Arix Bioscience losses narrow, expands portfolio to 13 companies

Arix Bioscience, which listed on the London Stock Exchange in February 2017, said annual losses narrowed, as it upped its ...

Annual Results 2017

RNS Number: 7040L Arix Bioscience Plc 23 April 2018 Annual Results 2017 LONDON, 23 April 2018: Arix Bioscience plc (LSE:ARIX) ("Arix Bioscience", "Arix" or the "Company"), a global life sciences company supporting medical innovation, today announces its annual results for the year ended 31 December 2017. Highlights within the period Successful IPO on the M...

Notice of Annual Results

RNS Number: 9492K Arix Bioscience Plc 16 April 2018 Notice of Annual Results and analyst briefing LONDON, 16 April, 2018: Arix Bioscience plc (LSE: ARIX), a global healthcare and life science company supporting medical innovation, will announce its annual results for the period ended 31 December 2017 on Monday 23 April 2018. Joe Anderson, Chief Executive O...

Fundamental DataMore

EPS-0.36
Dividend yield0 %

Latest discussion posts More

  • Full article

    Started by Miss Molly, page 47. Mail on Sunday.
    7-May-2018
    nondangerousdan
  • CASH INJECTION

    The world of drugs is changing fast. Once, big, international pharmaceutical companies were responsible for virtually every new product that came to market. Today however, ...
    6-May-2018
    missmolly
  • Re: welcome

    Mr Johnny Cash What on earth are you doing here? :-) Got fed up with telling the bickering children off on the IQE board I'll bet, silly s0ds will never learn.... I ...
    6-May-2018
    missmolly

Users' HoldingsMore

Users who hold Arix Bioscience also hold..

Codes & Symbols

ISINGB00BD045071
SymbolsARIX, LSE:ARIX, ARIX.L, ARIX:LN, LON:ARIX, XLON:ARIX